Relay Therapeutics, Inc. - Common Stock (RLAY)
CUSIP: 75943R102
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 177,447,642
- Total 13F shares
- 120,596,011
- Share change
- +7,528,921
- Total reported value
- $2,019,993,086
- Put/Call ratio
- 0%
- Price per share
- $16.75
- Number of holders
- 137
- Value change
- +$124,571,798
- Number of buys
- 83
- Number of sells
- 33
Quarterly Holders Quick Answers
What is CUSIP 75943R102?
CUSIP 75943R102 identifies RLAY - Relay Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75943R102:
Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
16%
|
27,904,963
|
$835,196,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
9.2%
|
16,242,006
|
$486,123,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
6,217,623
|
$186,093,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.4%
|
5,974,183
|
$178,807,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.8%
|
4,999,718
|
$149,642,000 | — | 31 Mar 2022 | |
| BVF INC/IL |
13F
|
Company |
2.6%
|
4,530,605
|
$135,601,000 | — | 31 Mar 2022 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.3%
|
4,050,688
|
$121,237,000 | — | 31 Mar 2022 | |
| Bellevue Group AG |
13F
|
Company |
2.2%
|
3,918,962
|
$117,295,000 | — | 31 Mar 2022 | |
| Casdin Capital, LLC |
13F
|
Company |
2.2%
|
3,857,253
|
$115,448,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.8%
|
3,274,389
|
$98,003,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
3,253,692
|
$97,383,000 | — | 31 Mar 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
1.5%
|
2,669,132
|
$79,887,000 | — | 31 Mar 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.3%
|
2,291,441
|
$68,583,000 | — | 31 Mar 2022 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.1%
|
2,025,114
|
$60,612,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.1%
|
2,020,514
|
$60,474,000 | — | 31 Mar 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.1%
|
1,943,097
|
$58,156,000 | — | 31 Mar 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1%
|
1,808,950
|
$54,142,000 | — | 31 Mar 2022 | |
| Alphabet Inc. |
13F
|
Company |
0.88%
|
1,568,753
|
$46,953,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.76%
|
1,352,477
|
$40,479,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
0.53%
|
937,926
|
$28,072,125 | — | 31 Mar 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.39%
|
700,000
|
$20,951,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.37%
|
650,351
|
$19,464,000 | — | 31 Mar 2022 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.34%
|
601,667
|
$18,008,000 | — | 31 Mar 2022 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.33%
|
584,463
|
$17,493,000 | — | 31 Mar 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.32%
|
574,447
|
$17,193,199 | — | 31 Mar 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.31%
|
549,055
|
$16,433,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.31%
|
544,590
|
$16,300,000 | — | 31 Mar 2022 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
0.3%
|
541,124
|
$16,196,000 | — | 31 Mar 2022 | |
| Nextech Invest Ltd. |
13F
|
Company |
0.27%
|
475,485
|
$14,231,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
431,480
|
$12,915,000 | — | 31 Mar 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.23%
|
411,403
|
$12,313,000 | — | 31 Mar 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.19%
|
331,663
|
$9,927,000 | — | 31 Mar 2022 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.18%
|
327,000
|
$9,787,000 | — | 31 Mar 2022 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.17%
|
304,054
|
$9,100,000 | — | 31 Mar 2022 | |
| Sessa Capital IM, L.P. |
13F
|
Company |
0.17%
|
301,200
|
$9,015,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.17%
|
300,771
|
$9,002,000 | — | 31 Mar 2022 | |
| HARBOURVEST PARTNERS LLC |
13F
|
Company |
0.17%
|
296,402
|
$8,871,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
286,886
|
$8,586,000 | — | 31 Mar 2022 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.15%
|
274,283
|
$8,209,000 | — | 31 Mar 2022 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.14%
|
244,277
|
$7,311,000 | — | 31 Mar 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.12%
|
204,883
|
$6,132,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
217,323
|
$5,631,000 | — | 31 Mar 2022 | |
| Fernwood Investment Management, LLC |
13F
|
Company |
0.1%
|
185,063
|
$5,539,000 | — | 31 Mar 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.1%
|
170,274
|
$5,096,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
116,521
|
$3,488,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.06%
|
102,200
|
$3,059,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
100,094
|
$2,995,000 | — | 31 Mar 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.06%
|
99,997
|
$2,993,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
97,779
|
$2,926,000 | — | 31 Mar 2022 | |
| ICONIQ Capital, LLC |
13F
|
Company |
0.05%
|
94,697
|
$2,834,000 | — | 31 Mar 2022 |
Institutional Holders of Relay Therapeutics, Inc. - Common Stock (RLAY) as of Q2 2022
As of 30 Jun 2022,
Relay Therapeutics, Inc. - Common Stock (RLAY) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
120,596,011 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, STATE STREET CORP, BVF INC/IL, Casdin Capital, LLC, and Bellevue Group AG.
This page lists
137
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
133
Q2 2022 holders
137
Holder diff
4
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.